Pemomab 100mg/4ml (Pembrolizumab)

Pemomab 100mg/4ml is an immunotherapy injection containing Pembrolizumab for adults with melanoma, lung cancer, and other advanced tumors. PakMeds only arranges Pemomab for patients with approval from attending oncologists and registered/authorized cancer hospitals.

This medication isn't available without a prescription. The patient must meet the necessary requirements, including DRAP NOC prerequisits.

Pemomab Ingredients and Usage

Pemomab contains Pembrolizumab, a PD-1 blocking monoclonal antibody known as an immune checkpoint inhibitor. PD-1 is a brake on immune cells that many tumors exploit to escape attack. Oncologists prescribe Pemomab for adults with melanoma, non small cell lung cancer (NSCLC), and head and neck squamous cell carcinoma.

Pemomab also treats urothelial cancer, advanced cervical cancer, and microsatellite instability high (MSI-H) or mismatch repair deficient tumors. A specialist gives Pemomab as an intravenous infusion, commonly 200mg every three weeks. Doctors may combine it with platinum based chemotherapy or paclitaxel, depending on the type of cancer.

How Does Pemomab Work?

Pemomab works by blocking PD-1, a receptor that normally stops T cells from attacking the body's own tissue. Many tumors display PD-L1, a protein that locks onto PD-1 and switches off the immune response. Pembrolizumab breaks this lock, freeing T cells to recognize and destroy cancer cells.

Pemomab strengthens the immune system rather than poisoning dividing cells the way traditional chemotherapy does. In clinical trials, Pembrolizumab improved survival across metastatic melanoma, lung cancer, and several other malignancies. Response depends on tumor type, PD-L1 levels, and overall health, so oncologists monitor progress closely.

Pemomab Side Effects

Pemomab can trigger immune related side effects when the activated immune system attacks healthy organs. Most reactions stay manageable when caught early, so report new symptoms to your oncology team without delay.

• Fatigue and general weakness

• Skin rash and itching

• Diarrhea or bowel inflammation (colitis)

• Nausea and decreased appetite

• Cough or shortness of breath (pneumonitis)

• Thyroid changes (underactive or overactive)

• Joint and muscle pain

• Fever or infusion reaction

• Liver inflammation (hepatitis)

• Raised blood sugar

Warnings

• Pemomab can cause severe immune mediated reactions in the lungs, liver, bowel, kidneys, and hormone glands. These reactions can become serious or fatal without prompt treatment.

• Infusion reactions such as fever, chills, and low blood pressure can occur during or shortly after administration.

• Pemomab may harm an unborn baby. Women must use effective contraception during treatment and for four months after the last dose.

• Tell your doctor about any autoimmune disease, organ transplant, or stem cell transplant before starting Pemomab.

• Avoid live vaccines during Pemomab therapy, since the activated immune system may react unpredictably.

• Counterfeit Keytruda is widespread across the region. Confirm every vial and buy pembrolizumab only through traceable sources, as explained in our fake Keytruda guide.

Pemomab Storage Conditions

Store Pemomab 100mg/4ml in a refrigerator between 2°C and 8°C inside its original carton to protect it from light. Never freeze or shake the vial, since this damages the Pembrolizumab antibody and lowers its effectiveness. Keep the vial out of reach of children, and let a trained professional handle dilution and infusion.